189 related articles for article (PubMed ID: 31783021)
1. Analytical validation of new ELISAs for the quantitation of polyclonal free light chains and comparison to existing assays for healthy and patient samples.
Heaney JLJ; Campbell JP; Goodall M; Plant T; Shemar M; Hand C; Drayson MT
J Immunol Methods; 2020 Mar; 478():112713. PubMed ID: 31783021
[TBL] [Abstract][Full Text] [Related]
2. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
3. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
5. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
6. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
[TBL] [Abstract][Full Text] [Related]
10. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
11. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
[TBL] [Abstract][Full Text] [Related]
13. N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda.
Velthuis HT; Knop I; Stam P; van den Broek M; Bos HK; Hol S; Teunissen E; Fischedick KS; Althaus H; Schmidt B; Wagner C; Melsert R
Clin Chem Lab Med; 2011 Aug; 49(8):1323-1332. PubMed ID: 21663464
[TBL] [Abstract][Full Text] [Related]
14. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
[TBL] [Abstract][Full Text] [Related]
15. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
16. Limitations of Free Light Chain Assays caused by the Matrix Effect.
Farnsworth CW; Logsdon NM; Hayes JE; Rais R; Willrich MA; Gronowski AM
J Appl Lab Med; 2020 Mar; 5(2):311-319. PubMed ID: 32445382
[TBL] [Abstract][Full Text] [Related]
17. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
[TBL] [Abstract][Full Text] [Related]
19. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
